FDA applicant
Alere Scarborough, Inc.
FDA records 17 decisions for Alere Scarborough, Inc. (Scarborough, ME) from 2012 to 2019: 16 510(k) clearances and 1 De Novo grant. Most are in product codes OCC (Respiratory Virus Panel Nucleic Acid Assay…) and PSZ (Devices Detecting Influenza A, B, And C Virus…). Since 2016 its 510(k)s took a median of 37 days from receipt to decision, against 113 for FDA’s reviews in the same codes and years. Its devices cite 20 predicates, 11 of them its own earlier devices. 4 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Alere Scarborough, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
2in 2019
2026 so far, outlined.
Recalls per year
1in 2026
Class I Class II/III not classified
Planning a device like Alere Scarborough, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Alere”
FDA records each applicant name separately; these may or may not be the same firm.